<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04709497</url>
  </required_header>
  <id_info>
    <org_study_id>Viscotrabeculotomy VI</org_study_id>
    <nct_id>NCT04709497</nct_id>
  </id_info>
  <brief_title>Surgery for Primary Congenital Glaucoma in Neonates</brief_title>
  <official_title>Surgery for Primary Congenital Glaucoma in Neonates:Randomized Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study aimed to compare between the long-term surgical outcomes of 3 surgical&#xD;
      options (viscotrabeculotomy (VT), visco-circumferential-suture-trabeculotomy (VCST) or&#xD;
      combined VT-Trabeculectomy with MMC (VT-Trab) in treatment of infants with (Primary&#xD;
      Congenital Glaucoma (PCG)) below 1 month of age.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomised controlled trial. We plan to recruit 60 infants with&#xD;
      primary congenital glaucoma and younger than 1 month of age at the outpatient clinic of&#xD;
      Mansoura Ophthalmic Center of Mansoura University in Mansoura, Egypt. Eyes will be randomly&#xD;
      assigned to undergo one of 3 surgical interventions: viscotrabeculotomy (VT),&#xD;
      visco-circumferential-suture-trabeculotomy (VCST) or combined VT-Trabeculectomy with MMC&#xD;
      (VT-Trab).&#xD;
&#xD;
      The primary outcome of this study is compare the success rate in lowering IOP between the 3&#xD;
      surgical options in infants with Primary Congenital Glaucoma (PCG) below 1 month of age. The&#xD;
      secondary clinical outcomes will include Intraocular pressure (IOP), horizontal corneal&#xD;
      diameter, axial length, cup-disc ratio, refractive error and postoperative complications in&#xD;
      these 3 surgical procedures. Data will be analysed. Complete success was defined as an IOP&#xD;
      from 5 to 16 mmHg (under general anesthesia), without antiglaucoma drugs (AGD) or further&#xD;
      surgical interventions, without progression of corneal diameter or disk cupping, and without&#xD;
      serious visual complications. Qualified success was defined as fulfilling the same criteria&#xD;
      but with the use of AGD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>success rate in lowering intraocular pressure (IOP)</measure>
    <time_frame>3 years</time_frame>
    <description>Complete success was defined as an IOP from 5 to 16 mmHg (under general anesthesia), without AGD or further surgical interventions, without progression of corneal diameter or disk cupping, and without serious visual complications. Qualified success was defined as fulfilling the same criteria but with the use of AGD.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>horizontal corneal diameter</measure>
    <time_frame>3 years</time_frame>
    <description>The change in &quot;white to white&quot; corneal diameters in mm measured by caliber.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>axial length</measure>
    <time_frame>3 years</time_frame>
    <description>The change in axial length in mm measured by ultrasonography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cup-disc ratio</measure>
    <time_frame>3 years</time_frame>
    <description>The change in cup -disc ratio as measured by optical coherence tomography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>refractive error</measure>
    <time_frame>3 years</time_frame>
    <description>The change in refractive error as measured by autorefractometer..</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Primary Congenital Glaucoma</condition>
  <arm_group>
    <arm_group_label>viscotrabeculotomy (VT)).</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>visco-circumferential-suture-trabeculotomy (VCST)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined VT-Trabeculectomy with MMC (VT-Trab).</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>viscotrabeculotomy (VT)</intervention_name>
    <description>viscotrabeculotomy (VT)</description>
    <arm_group_label>viscotrabeculotomy (VT)).</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>visco-circumferential-suture-trabeculotomy (VCST) .</intervention_name>
    <description>visco-circumferential-suture-trabeculotomy (VCST)</description>
    <arm_group_label>visco-circumferential-suture-trabeculotomy (VCST)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>combined VT-Trabeculectomy with MMC (VT-Trab).</intervention_name>
    <description>combined VT-Trabeculectomy with MMC (VT-Trab).</description>
    <arm_group_label>Combined VT-Trabeculectomy with MMC (VT-Trab).</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Primary Congenital Glaucoma in Neonates&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        secondary Congenital Glaucoma in Neonates. Congenital Glaucoma presented after 1 month of&#xD;
        age.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>30 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amr M Mohammed, MD</last_name>
    <phone>1004314242</phone>
    <phone_ext>+20</phone_ext>
    <email>dramrabdelkader@gmail.com</email>
  </overall_contact>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 9, 2021</study_first_submitted>
  <study_first_submitted_qc>January 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2021</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Amr Mohammed Elsayed Abdelkader</investigator_full_name>
    <investigator_title>Lecturer of ophthalmology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Hydrophthalmos</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>providing data as supplemental digital content</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

